Chronic Pain: Reducing Costs Through Early Implementation of Adherence Testing and Recognition of Opioid Misuse

References

• . McCarberg BH, Billington R. Consequences of neuropathic pain: Quality-of-life issues and associated costs. Am J Manag Care. 2006; 12( suppl 9):S263–S268
   PubMed Web of Science ®Google Scholar
• . The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and American Pain Society. Clin J Pain. 1997; 13(1):6–8
   PubMedGoogle Scholar
• . National Institutes of Health. New directions in pain research: I. PA-98–102; September 4, 1998. http://grants.nih.gov/grants/guide/pa-files/PA-98–102.html. Accessed November 18, 2010
   Google Scholar
• . Kim Le T, Montejano L, Johnston J, . Comparison of healthcare expenditures associated with different chronic pain conditions. 26th Annual Meeting of the American Academy of Pain Medicine (AAPM); February 3, 2010; San Antonio, TX. http://www.aapainmanage.org/pain_management_news/NEW_newsletter/landingpage/research0310.html. Accessed December 7, 2010
   Google Scholar
• . Zagari MJ, Mazonson PD, Longton WC. Pharmacoeconomics of chronic nonmalignant pain. Pharmacoeconomics. 1996; 10(4):356–377
   PubMed Web of Science ®Google Scholar
• . Burgoyne DS. Prevalence and economic implications of chronic pain. Manag Care. 2007; 16(2 suppl 3):2–4
   PubMedGoogle Scholar
• . Hitchcock LS, Ferrell BR, McCaffery M. The experience of chronic nonmalignant pain. J Pain Symptom Manage. 1994; 9(5):312–318
   PubMed Web of Science ®Google Scholar
• . American Pain Society. Chronic pain in America: roadblocks to relief, a study conducted by Roper Starch Worldwide for American Academy of Pain Medicine, American Pain Society, and Janssen Pharmaceutica, 1999. http://www.ampainsoc.org/resources/roadblocks/summary2_road.htm. Accessed November 8, 2010
   Google Scholar
• . Katz WA, Barkin RL. Dilemmas in chronic/persistent pain management. Am J Ther. 2008; 15(3):256–264
   PubMed Web of Science ®Google Scholar
• . Chou R, Fanciullo GJ, Fine PG, ; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of opioid therapy in chronic noncancer pain. J Pain. 2009; 10(2):113–130
   PubMed Web of Science ®Google Scholar
• . Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008; 9(4):444–459
   PubMed Web of Science ®Google Scholar
• . Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992; 8(2):77–85
   PubMed Web of Science ®Google Scholar
• . Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain. 2007; 23(4):307–315
   PubMed Web of Science ®Google Scholar
• . Michna E, Jamison RN, Pham LD, . Urine toxicology screening among chronic pain patients on opioid therapy: Frequency and predictability of abnormal findings. Clin J Pain. 2007; 23(2):173–179
   PubMed Web of Science ®Google Scholar
• . Trescot AM, Helm S, Hansen H, . Opioids in the management of chronic non-cancer pain: An update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician. 2008; 11( suppl 2):S5–S62
   PubMed Web of Science ®Google Scholar
• . National Drug Intelligence Center, US Department of Justice. Methadone diversion, abuse, and misuse: deaths increasing at alarming rate. Product No. 2007-Q0317–001; November 2007. http://www.justice.gov/ndic/pubs25/25930/25930p.pdf. Accessed November 25, 2010
   Google Scholar
• . Portenoy RK. Opioid therapy for chronic nonmalignant pain: A review of the critical issues. J Pain Symptom Manage. 1996; 11(4):203–217
   PubMed Web of Science ®Google Scholar
• . Pergolizzi J, Pappagallo M, Stauffer J, ; Integrated Drug Compliance Study Group (IDCSG). The role of urine drug testing for patients on opioid therapy. Pain Pract. 2010; 10(6):497–507
   PubMed Web of Science ®Google Scholar
• . Heit HA, Gourlay DL. DSM-V and the definitions: Time to get it right. Pain Med. 2009; 10(5):784–786
   PubMed Web of Science ®Google Scholar
• . Savage SR, Joranson DE, Covington EC, Schnoll SH, Heit HA, Gilson AM. Definitions related to the medical use of opioids: Evolution towards universal agreement. J Pain Symptom Manage. 2003; 26(1): 655–667
   PubMed Web of Science ®Google Scholar
• . Goldberg GA, Kim SS, Seifeldin R, Patton MP, Haberman M. Health care costs associated with suboptimal management of persistent pain. Manag Care. 2003; 12(8):14–17
   PubMedGoogle Scholar
• . Ruetsch CR. Empirical view of opioid dependence. J Manag Care Pharm. 2010; 16( suppl 1B):S9–S13
   PubMed Web of Science ®Google Scholar
• . Manchikanti L. Prescription drug abuse: What is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources. Pain Physician. 2006; 9(4): 287–321
   PubMedGoogle Scholar
• . Leider HL, Dhaliwal J, Davis EJ, Kulakodlu M, Buikema AR. Healthcare costs and nonadherence among chronic opioid users. Am J Manag Care. 2011; 17(1):32–40
   PubMed Web of Science ®Google Scholar
• . Manchikanti L, Manchukonda R, Pampati V, . Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician. 2006; 9(2):123–129
   PubMedGoogle Scholar
• . Katz NP, Sherburne S, Beach M, . Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003; 97(4):1097–1102
   PubMed Web of Science ®Google Scholar
• . Trescot AM, Boswell MV, Atluri SL, . Opioid guidelines in the management of chronic non-cancer pain. Pain Physician. 2006; 9(1):1–39
   PubMedGoogle Scholar
• . Jan SA. Patient perspective, complexities, and challenges in managed care. J Manag Care Pharm. 2010; 16( suppl 1B):S22–S25
   PubMed Web of Science ®Google Scholar
• . Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003; 290(18):2443–2454
   PubMed Web of Science ®Google Scholar
• . White AG, Birnbaum HG, Mareva MN, . Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm. 2005; 11(6):469–479
   PubMedGoogle Scholar
• . Portenoy RK. Acute and chronic pain. In: Ruiz P, Strain E, eds. Lowinson and Ruiz's Substance Abuse: A Comprehensive Textbook. 5th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2011; 695–720
   Google Scholar
• . Manchikanti L, Benyamin R, Datta S, Vallejo R, Smith H. Opioids in chronic noncancer pain. Expert Rev Neurother. 2010; 10(5):775–789
   PubMed Web of Science ®Google Scholar
• . Manchikanti L, Atluri S, Trescot AM, Giordano J. Monitoring opioid adherence in chronic pain patients: Tools, techniques, and utility. Pain Physician. 2008; 11( suppl 2):S155–S180
   PubMed Web of Science ®Google Scholar
• . Gilbert JW, Wheeler GR, Mick GE, . Urine drug testing in the treatment of chronic noncancer pain in a Kentucky private neuroscience practice: The potential effect of Medicare benefit changes in Kentucky. Pain Physician. 2010; 13(2):187–194
   PubMed Web of Science ®Google Scholar
• . Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manag. 2004; 27(3):260–267
   PubMed Web of Science ®Google Scholar
• . Evans M, Kriger S, Gunn J, Schwilke G. Compliance monitoring and effective risk mitigation strategy. Practical Pain Management. 2010; 10(5):43–46
   Google Scholar
• . Hammett-Stabler CA, Webster LR. A Clinical Guide to Urine Drug Testing: Augmenting Pain Management and Enhancing Patient Care. Newark, NJ: UMDNJ–Center for Continuing and Outreach Education; 2008
   Google Scholar
• . iCup [package insert]. Norfolk, VA: Instant Technologies; 2005
   Google Scholar
• . Buckley NA. Abnormal laboratory results: Drug screens. Australian Prescriber. 2001; 24(4):90–91
   Google Scholar
• . Neafsey P, Ginsberg G, Hattis D, Sonawane B. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity. J Toxicol Environ Health B Crit Rev. 2009; 12(5–6): 334–361
   PubMed Web of Science ®Google Scholar
• . Goldstein JA. Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol. 2001; 52(4):349–355
   PubMed Web of Science ®Google Scholar
• . Shulman RW, Özdemir V. Psychotropic medications and cytochrome P450 2D6: Pharmacokinetic considerations in the elderly. Can J Psychiatry 1997; 42( 1 suppl):4S–9S
   Web of Science ®Google Scholar
• . Evans M, Kriger S, Gunn J, Schwilke G. Effective monitoring of opiates in chronic pain patients. Practical Pain Management. 2009; 9(6):32–33
   Google Scholar
• . Centers for Medicare and Medicaid Services. Medicare fee schedules. http://www.cms.gov/ClinicalLabFeeSched/02_clinlab.asp#TopOfPage. Accessed January 4, 2011
   Google Scholar